HIGHFDA DRUG
Granules Pharmaceuticals Recalls Dextroamphetamine Capsules for Impurities
Granules Pharmaceuticals Inc. recalled 11,895 bottles of extended-release capsules on August 28, 2025. The capsules failed impurities and degradation specifications. Consumers should stop using the product immediately, as it could pose health risks.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Failed Impurities/Degradation